3 | SEC Filings Hub

Filing metadata

Accession number: 0001062993-21-000056
Form type: Form 3
Filer: Trillium Therapeutics Inc.
CIK: CIK 1616212
Filed: Jan 04, 2021
Reporting period: Jan 01, 2021
Description: Initial ownership

Documents

0001062993-21-000056-index.htm

Complete submission

0001062993-21-000056.txt

directory listing

Filed by

Trillium Therapeutics Inc.